PAHO.
RECAINSA.
Stud Health Technol Inform. 2022 May 25;294:694-698. doi: 10.3233/SHTI220558.
During the COVID-19 pandemic, the Pan American Health Organization (PAHO) promoted several activities to strengthen the countries' emergency response. Vaccines represented a breakthrough in the pandemic evolution, even though they have not been equitably distributed. As most vaccines have received emergency authorizations for their timely delivery, vaccine safety surveillance has been highlighted for detecting early signals of potential adverse events following immunization (AEFI, also known as ESAVI). The objective of this article is to share the different steps, methodologies, and preliminary results of a regional policy to strengthen the ESAVI surveillance system in the Americas, including the adoption of HL7 FHIR for health information exchange between countries and PAHO.
在 COVID-19 大流行期间,泛美卫生组织(PAHO)推动了多项活动,以加强各国的应急响应。疫苗的出现是大流行演变过程中的一个突破,尽管它们的分配并不公平。由于大多数疫苗都因及时交付而获得了紧急授权,因此疫苗安全性监测已成为发现潜在疫苗接种后不良反应(AEFI,也称为 ESAVI)早期信号的重点。本文的目的是分享一项加强美洲 ESAVI 监测系统的区域政策的不同步骤、方法和初步结果,包括采用 HL7 FHIR 进行国家间和 PAHO 的卫生信息交换。